Hirosaki University, Ezose unite to identify prostate cancer biomarkers

04/24/2012 | GenomeWeb Daily News (free registration)

Japan's Hirosaki University and Ezose Sciences agreed to work together to find biomarkers that can be used to predict and monitor the progress of prostate cancer and other urological cancers. Ezose will receive development and commercialization rights to the biomarkers.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ